Show simple item record

dc.creatorHeslop, Helenen
dc.creatorRooney, Clionaen
dc.creatorBrenner, Malcolmen
dc.creatorKrance, Roberten
dc.creatorCarrum, Georgeen
dc.creatorGahn, Benedikten
dc.creatorBollard, Catherineen
dc.creatorKhan, Shakilaen
dc.creatorGee, Adrianen
dc.creatorPopat, Udayen
dc.creatorGresik, Maryen
dc.creatorPrzepiorka, Donnaen
dc.creatorKuehnle, Ingriden
dc.creatorGrilley, Bambien
dc.date.accessioned2011-07-12T18:23:14Zen
dc.date.available2011-07-12T18:23:14Zen
dc.date.created2000-07-01en
dc.date.issued2000-07-01en
dc.identifier.bibliographicCitationHuman Gene Therapy 2000 July 1; 11(10): 1465-1475en
dc.identifier.urihttp://hdl.handle.net/10822/516328en
dc.formatArticleen
dc.languageengen
dc.source220255en
dc.subjectBone Marrowen
dc.subjectDiseaseen
dc.subjectPatientsen
dc.subject.classificationGene Therapy / Gene Transferen
dc.subject.classificationInformed Consent or Human Experimentationen
dc.subject.classificationResearch on Special Populationsen
dc.titleAdministration of Neomycin Resistance Gene-Marked EBV-Specific Cytotoxic T-Lymphocytes as Therapy for Patients Receiving a Bone Marrow Transplant for Relapsed EBV-Positive Hodgkin Diseaseen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885